CFL1 and Alzheimer disease: In the hippocampal synapses of AD patients and mouse models, there is an increase in cofilin levels accompanied by a reduction in CAP2 synaptic availability, leading to a decrease in CAP2 dimer formation at the synapse (Pelucchi et al., 2020).